-+ 0.00%
-+ 0.00%
-+ 0.00%

XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™

Barchart·09/10/2026 15:05:00
语音播报

● Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval ●

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.